Skip to content
Disclosery

Deep Track Capital, LP

Follow

13F filer, CIK 1856083, GREENWICH, CT

Deep Track Capital, LP reported $3,118,189,972 across 66 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 52.57% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001856083-25-000004

Period
2025-06-30
Reported value
$3.12B
Holdings
66
Top 10 weight
52.57%
New
8
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
INSMadded+1,495,249$150M
AXSMnew+801,371$83.7M
PCVXadded+1,400,000$45.5M
APLSadded+2,000,000$34.6M
JBIOnew+2,509,301$25.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INTRA-CELLULAR THERAPIES INCexited-2,000,000-$264M
BBIOreduced-1,900,000-$82M
GHreduced-1,193,721-$62.1M
AMGNexited-113,035-$35.2M
EWTXexited-1,400,000-$30.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001856083-25-000004, largest first. % of portfolio is the value over $3,110,494,972, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,000,560 shares; 2024Q4: 6,419,566 shares; 2025Q1: 5,443,721 shares; 2025Q2: 4,250,000 shares 4,250,000$221M7.11%-1,193,721Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,200,000 shares; 2024Q4: 1,933,928 shares; 2025Q1: 4,564,207 shares; 2025Q2: 4,891,544 shares 4,891,544$193M6.21%+327,337Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,000,000 shares; 2025Q1: 3,000,000 shares; 2025Q2: 3,245,899 shares 3,245,899$179M5.77%+245,899Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,526,486 shares; 2024Q4: 17,791,486 shares; 2025Q1: 17,791,486 shares; 2025Q2: 17,791,486 shares 17,791,486$176M5.67%0Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 254,751 shares; 2025Q2: 1,750,000 shares 1,750,000$176M5.66%+1,495,249Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 689,784 shares; 2024Q4: 1,490,000 shares; 2025Q1: 3,210,270 shares; 2025Q2: 3,042,598 shares 3,042,598$162M5.22%-167,672Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,347,464 shares; 2024Q4: 6,000,000 shares; 2025Q1: 9,500,000 shares; 2025Q2: 9,500,000 shares 9,500,000$152M4.89%0Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,721,460 shares; 2024Q4: 12,836,282 shares; 2025Q1: 14,294,420 shares; 2025Q2: 14,294,420 shares 14,294,420$133M4.26%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,400,654 shares; 2024Q4: 4,274,921 shares; 2025Q1: 5,000,000 shares; 2025Q2: 7,000,000 shares 7,000,000$121M3.9%+2,000,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 629,906 shares; 2024Q4: 2,500,000 shares; 2025Q1: 3,073,853 shares; 2025Q2: 3,650,000 shares 3,650,000$121M3.88%+576,147Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,220,508 shares; 2024Q4: 2,800,000 shares; 2025Q1: 4,100,000 shares; 2025Q2: 5,133,917 shares 5,133,917$106M3.42%+1,033,917Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,766,512 shares; 2024Q4: 6,478,249 shares; 2025Q1: 9,316,333 shares; 2025Q2: 9,500,000 shares 9,500,000$93.3M3%+183,667
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 857,219 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 801,371 shares 801,371$83.7M2.69%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,750,945 shares; 2024Q4: 4,522,741 shares; 2025Q1: 5,380,449 shares; 2025Q2: 5,380,449 shares 5,380,449$75.2M2.42%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,484,266 shares; 2025Q2: 1,750,000 shares 1,750,000$70.9M2.28%+265,734Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 750,000 shares; 2025Q2: 2,150,000 shares 2,150,000$69.9M2.25%+1,400,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,868,104 shares; 2024Q4: 3,000,000 shares; 2025Q1: 5,500,000 shares; 2025Q2: 6,064,910 shares 6,064,910$69.1M2.22%+564,910Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,575,049 shares; 2024Q4: 4,011,287 shares; 2025Q1: 38,176,251 shares; 2025Q2: 43,000,000 shares 43,000,000$60.6M1.95%+4,823,749Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 519,376 shares; 2025Q1: 1,411,402 shares; 2025Q2: 1,800,000 shares 1,800,000$56.5M1.82%+388,598Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 653,513 shares; 2025Q1: 1,350,000 shares; 2025Q2: 1,350,000 shares 1,350,000$49.1M1.58%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,269,126 shares; 2025Q2: 3,948,910 shares 3,948,910$48.5M1.56%+679,784Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 504,828 shares; 2024Q4: 649,042 shares; 2025Q1: 700,000 shares; 2025Q2: 700,000 shares 700,000$45.7M1.47%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 169,132 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,350,000 shares 1,350,000$42.3M1.36%+350,000Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,357,702 shares; 2025Q2: 2,233,148 shares 2,233,148$41.6M1.34%-124,554Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,540,132 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares 2,000,000$40.7M1.31%0Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 819,162 shares; 2025Q1: 2,800,000 shares; 2025Q2: 900,000 shares 900,000$38.9M1.25%-1,900,000Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,272,172 shares; 2024Q4: 14,218,903 shares; 2025Q1: 17,849,482 shares; 2025Q2: 16,852,147 shares 16,852,147$38.4M1.24%-997,335Timeline
MTSRMETSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,094,408 shares; 2025Q2: 1,094,408 shares 1,094,408$31.1M1%0Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,576,558 shares; 2024Q4: 5,576,558 shares; 2025Q1: 5,576,558 shares; 2025Q2: 7,495,000 shares 7,495,000$28M0.9%+1,918,442Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,401,938 shares; 2025Q2: 1,401,938 shares 1,401,938$27.9M0.9%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,579,209 shares; 2024Q4: 3,579,209 shares; 2025Q1: 3,579,209 shares; 2025Q2: 3,480,144 shares 3,480,144$26.6M0.86%-99,065Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,509,301 shares 2,509,301$25.1M0.81%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,018,935 shares; 2024Q4: 3,018,935 shares; 2025Q1: 3,018,935 shares; 2025Q2: 2,188,592 shares 2,188,592$25M0.8%-830,343Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,859,648 shares; 2025Q2: 8,831,007 shares 8,831,007$24.7M0.79%-28,641Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares 2,000,000$24.4M0.78%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 796,852 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,426,657 shares 2,426,657$22.5M0.72%+426,657Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,235,187 shares; 2024Q4: 750,000 shares; 2025Q1: 1,444,709 shares; 2025Q2: 1,918,798 shares 1,918,798$21.5M0.69%+474,089Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,607,633 shares; 2024Q4: 4,557,575 shares; 2025Q1: 4,557,575 shares; 2025Q2: 4,557,575 shares 4,557,575$16.6M0.53%0Timeline
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,065,099 shares; 2024Q4: 2,816,594 shares; 2025Q1: 2,500,000 shares; 2025Q2: 2,500,000 shares 2,500,000$16.2M0.52%0
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,000,000 shares; 2025Q1: 2,299,567 shares; 2025Q2: 1,442,767 shares 1,442,767$15.8M0.51%-856,800Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,000,000 shares; 2024Q4: 3,442,833 shares; 2025Q1: 3,442,833 shares; 2025Q2: 3,442,833 shares 3,442,833$14.7M0.47%0Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 275,000 shares 275,000$14.5M0.47%new
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,529,987 shares; 2024Q4: 1,529,987 shares; 2025Q1: 1,529,987 shares; 2025Q2: 1,529,987 shares 1,529,987$12.8M0.41%0Timeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 250,000 shares 250,000$12.2M0.39%newTimeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,548,001 shares; 2024Q4: 1,276,081 shares; 2025Q1: 767,016 shares; 2025Q2: 1,203,244 shares 1,203,244$8.36M0.27%+436,228Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 453,686 shares 453,686$7.32M0.24%newTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,350,000 shares; 2024Q4: 1,350,000 shares; 2025Q1: not reported; 2025Q2: 500,000 shares 500,000$6.57M0.21%newTimeline
NVAXNOVAVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,000,000 shares; 2025Q1: 1,518,182 shares; 2025Q2: 998,542 shares 998,542$6.29M0.2%-519,640Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,953,937 shares; 2024Q4: 10,689,603 shares; 2025Q1: 9,722,254 shares; 2025Q2: 8,585,980 shares 8,585,980$6.14M0.2%-1,136,274Timeline
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 751,422 shares 751,422$6.01M0.19%newTimeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,419,355 shares; 2024Q4: 7,419,355 shares; 2025Q1: 7,419,355 shares; 2025Q2: 7,419,355 shares 7,419,355$4.86M0.16%0Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,972,257 shares; 2024Q4: 5,972,257 shares; 2025Q1: 5,399,681 shares; 2025Q2: 3,947,807 shares 3,947,807$4.58M0.15%-1,451,874Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 899,731 shares; 2025Q2: 259,800 shares 259,800$4.44M0.14%-639,931Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 800,000 shares; 2024Q4: 500,000 shares; 2025Q1: 549,439 shares; 2025Q2: 549,439 shares 549,439$4.32M0.14%0Timeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,804,366 shares; 2024Q4: 3,119,162 shares; 2025Q1: 3,119,162 shares; 2025Q2: 1,981,370 shares 1,981,370$4.03M0.13%-1,137,792Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 850,000 shares; 2024Q4: 874,614 shares; 2025Q1: 874,614 shares; 2025Q2: 277,966 shares 277,966$3.47M0.11%-596,648Timeline
IKENA ONCOLOGY INCIKENA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,515,513 shares; 2025Q2: 2,515,513 shares 2,515,513$3.37M0.11%0
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,000,000 shares; 2024Q4: 219,015 shares; 2025Q1: 219,015 shares; 2025Q2: 219,015 shares 219,015$3.28M0.11%0Timeline
ALGSALIGOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 244,110 shares; 2024Q4: 244,110 shares; 2025Q1: 444,110 shares; 2025Q2: 444,110 shares 444,110$3.2M0.1%0Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 967,000 shares; 2024Q4: 867,000 shares; 2025Q1: 859,876 shares; 2025Q2: 567,103 shares 567,103$2.83M0.09%-292,773Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,283,783 shares; 2024Q4: 3,283,783 shares; 2025Q1: 3,283,783 shares; 2025Q2: 1,727,562 shares 1,727,562$1.81M0.06%-1,556,221Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,169,143 shares; 2024Q4: 1,040,115 shares; 2025Q1: 1,040,115 shares; 2025Q2: 1,040,115 shares 1,040,115$1.29M0.04%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,912,929 shares; 2025Q1: 1,912,929 shares; 2025Q2: 121,716 shares 121,716$1.29M0.04%-1,791,213Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 457,556 shares; 2025Q2: 98,237 shares 98,237$1.12M0.04%-359,319Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 523,989 shares; 2025Q1: 523,989 shares; 2025Q2: 180,510 shares 180,510$431K0.01%-343,479Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SRPTSAREPTA THERAPEUTICS INC COMput450,000$7.7Mnew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC2,000,000$264Mshares
AMGNAMGEN INC113,035$35.2Mshares
EWTXEDGEWISE THERAPEUTICS INC1,400,000$30.8Mshares
DYNDYNE THERAPEUTICS INC2,000,000$20.9Mshares
LKFTLAKEFRONT BIOTHERAPEUTICS NV741,068$18.6Mshares
SAGE THERAPEUTICS INCSAGE THERAPEUTICS INC2,038,845$16.2Mshares
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC6,011,380$7.33Mshares
BEAMBEAM THERAPEUTICS INC315,765$6.17Mshares
REGULUS THERAPEUTICS INCREGULUS THERAPEUTICS INC3,262,564$5.71Mshares
ALLAKOS INCALLAKOS INC7,232,701$1.65Mshares
NGNENEUROGENE INC116,660$1.37Mshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001856083-25-000004 base2025-08-14acceptance time not in the bulk data set